Inovio and Collaborators Receive NIH Grant to Evaluate HIV Immunotherapy PENNVAX®-GP’s Ability to … – GuruFocus.com
|
Inovio and Collaborators Receive NIH Grant to Evaluate HIV Immunotherapy PENNVAX®-GP’s Ability to …
GuruFocus.com Development of Inovioâs PENNVAX-GP immunotherapy, which widely targets multiple major clades of HIV â providing global coverage â has been funded through a $25 million NIAID contract awarded to Inovio and its collaborators. In addition, Inovio and its … |
